Vapotherm’s HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America’s Largest Health Care Market
EXETER, N.H., Feb. 29, 2024 /PRNewswire/ — Vapotherm, Inc. (OTCQX: VAPO), (“Vapotherm” or the “Company”), a global medical technology company specializing in the development and commercialization of its proprietary Vapotherm high-velocity therapy® products for patients of all ages experiencing respiratory distress, is pleased to announce the regulatory approval of the HVT 2.0 system in Brazil. … Read more